Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-15 4:18 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | TCG Crossover GP II LLC | 20,046,350 9.9% | 20,046,350 (New Position) | View |
| 2024-02-15 4:20 pm Purchase | 13G | MINERALYS THERAPEUTICS INC MLYS | TCG Crossover GP II LLC | 3,185,185 6.4% | 3,185,185 (New Position) | View |
| 2024-02-15 4:17 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | TCG Crossover GP II LLC | 20,763,572 9.9% | 20,763,572 (New Position) | View |
| 2024-01-16 4:18 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | TCG Crossover GP II LLC | 4,368,928 9.9% | 4,368,928 (New Position) | View |
| 2023-10-16 4:37 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | TCG Crossover GP II LLC | 2,702,157 9.9% | 2,702,157 (New Position) | View |